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1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) is the biologically active ligand for the vitamin D receptor (VDR).
VDR/ mice have a hair follicle-cycling defect resulting in alopecia. However, mice lacking 25-hydroxyvitamin
D3 1a-hydroxylase (CYP27B1
/), and having no circulating 1,25(OH)2D3, have normal follicular function. These
mouse models indicate that VDR functions independently of 1,25(OH)2D3 in regulating hair-follicle cycling.
Here, we show that VDR/ mice rapidly develop chemically induced skin tumors, whereas CYP27B1/ and
wild-type mice do not, indicating that VDR, and not the 1,25(OH)2D3 ligand, is essential for protection against
skin tumorigenesis. Because the majority of human skin cancer results from exposure to UV, the susceptibility
of VDR/mice to this carcinogen was also evaluated. VDR/mice developed UV-induced tumors more rapidly
and with greater penetrance than did VDRþ /þ mice. p53 protein levels were upregulated at similar rates in
UV-treated keratinocytes of VDR/ and VDRþ /þ mice. However, rates of thymine-dimer repair and UV-induced
apoptosis were significantly lower in VDR/ epidermis compared with the wild type epidermis. UV-induced
epidermal thickening was also attenuated in VDR/ skin, indicating that VDR plays a critical role in the repair
and removal of severely damaged keratinocytes and adaptation of the skin to chronic UV exposure.
Journal of Investigative Dermatology (2008) 128, 2508–2517; doi:10.1038/jid.2008.131; published online 29 May 2008
INTRODUCTION
Approximately one million people are diagnosed with non-
melanoma skin cancer each year, which accounts for half of
all diagnosed tumors. The incidence of non-melanoma skin
cancer is increasing and, while rarely fatal, poses significant
health care challenges (Albert and Weinstock, 2003). The
vitamin D endocrine system protects against multiple forms
of carcinogenesis, but its significance in skin tumorigenesis is
only beginning to be appreciated (Zinser et al., 2002; Bikle,
2004). In addition, the molecular mechanisms that govern the
activity of the vitamin D endocrine system in the skin remain
unclear.
The biologically active form of vitamin D is 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3). This hormone binds
the vitamin D receptor (VDR) and promotes association with
its heterodimeric partner, the retinoid X receptor (Kliewer
et al., 1992; Cheskis and Freedman, 1994). The VDR–retinoid
X receptor heterodimer regulates transcription by binding to
specific response elements in the promoter regions of target
genes (Kerner et al., 1989). Synthesis of 1,25(OH)2D3 is
highly regulated and involves several tissues. Vitamin D
prohormone is produced primarily in the skin, where
7-dehydrocholesterol is converted to vitamin D by UV light.
Bioactivation of vitamin D occurs through sequential hydro-
xylation at C-25 in the liver and at C-1 in the kidney (Holick,
2007). The renal 25-hydroxyvitamin D 1a-hydroxylase
(1aOHase) enzyme is required to generate circulating levels
of 1,25(OH)2D3 in humans and other mammals (Gray et al.,
1972; St-Arnaud et al., 1997; Dardenne et al., 2001; Panda
et al., 2001).
Knockout mouse models have provided important physio-
logical insights into the vitamin D endocrine system. Four
independent strains of mice have been generated in which
the VDR has been inactivated (that is, receptor-knockout
mice) (Li et al., 1997; Yoshizawa et al., 1997; Van Cromphaut
et al., 2001; Erben et al., 2002). Two additional strains of
mice were engineered to target the CYP27B1 gene, which
encodes the renal 1aOHase enzyme (that is, ligand-knockout
mice) (Dardenne et al., 2001; Panda et al., 2001). CYP27B1/
mice are devoid of circulating 1,25(OH)2D3. As expected,
receptor- and ligand-knockout mice have similar phenotypes
relating to mineral homeostasis, manifesting as hypocalcemia,
hyperparathyroidism, and skeletal defects such as rickets.
Interestingly, this phenotype is corrected by feeding the mice a
diet high in calcium, phosphorus, and lactose, suggesting that
the significance of the vitamin D endocrine system in the
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skeletal system is secondary to its role in maintaining adequate
absorption of dietary calcium by the intestine (Li et al., 1998;
Dardenne et al., 2003).
Importantly, the VDR- and ligand-knockout mice (VDR/
and CYP27B1/, respectively) differ greatly in their skin
phenotypes. VDR/ mice develop an initial postnatal
coat of hair, but subsequent hair-follicle cycling fails leading
to alopecia (Li et al., 1998). Hair follicles degenerate to form
dermal cysts and utriculi (Li et al., 1998), and epidermal
keratinocytes proliferate at approximately twice the normal
rate (Zinser et al., 2002). This phenotype is not corrected
by a high-calcium diet, indicating that it is a direct
consequence of VDR inactivation (Li et al., 1998). In contrast,
CYP27B1/mice have normal hair-follicle cycling, a normal
keratinocyte proliferative index, and display only minor
differences in the expression of skin differentiation marker
proteins (Bikle et al., 2004). The lack of phenotype in
CYP27B1/ skin, as compared with the VDR/ skin,
strongly suggests that VDR regulates transcription in kerati-
nocytes independently of its 1,25(OH)2D3 ligand. Indeed,
recent data demonstrating a 1,25(OH)2D3-independent tran-
scriptional activity of the VDR selectively in human and
mouse keratinocytes provide key support for this concept
(Ellison et al., 2007).
Genetic inactivation of VDR also increases susceptibility
of mice to chemically induced skin tumorigenesis. VDR/
mice rapidly develop skin tumors following oral administra-
tion of dimethylbenzathracene (DMBA), whereas wild-type
mice are resistant to tumor development (Zinser et al., 2002).
Pharmacological doses of 1,25(OH)2D3 have been shown to
increase latency and reduce multiplicity of chemically
induced skin tumor formation in mice (Chida et al., 1985).
However, it is presently unknown whether CYP27B1/ mice
show altered susceptibility to DMBA-induced skin carcino-
genesis. Although chemical carcinogenesis protocols provide
a convenient way to study tumorigenesis in rodents over a
relatively short time period, the major environmental risk
factor in human skin carcinogenesis is exposure to UV light
(Albert and Weinstock, 2003). UV light, particularly UVB
with wavelengths between 290 and 320nm, causes DNA
damage, including formation of cyclobutane pyrimidine
dimers (Setlow and Setlow, 1962) and (6–4) photoproducts
(Johns et al., 1964). Failure to adequately repair or remove a
damaged cell may yield a mutated cell with the potential
ability to clonally expand and become tumorigenic. There-
fore, it is critical to evaluate whether VDR also plays a
protective role against UV-induced tumorigenesis, and if so,
to evaluate the mechanisms underlying this protective
activity of VDR.
In this report, we provide evidence that VDR, but not its
1,25(OH)2D3 ligand, is required for in vivo resistance to
chemically induced skin tumorigenesis in mice. Furthermore,
we show that VDR is essential for protection against
UV-induced skin carcinogenesis. This striking difference in
UV-induced tumor susceptibility may be due, in part, to a
significant reduction in thymine-dimer repair and keratino-
cyte apoptosis in VDR/ skin following acute exposure to
UV light. In addition, VDR/ skin shows reduced epidermal
thickening in response to repeated UV exposure, indicating
that VDR/ skin does not mount an appropriate protective
response to UV, leaving basal keratinocytes more exposed to
penetrating UV rays.
RESULTS
Protection against chemically induced skin tumorigenesis is
VDR-dependent and 1aOHase-independent in mice
VDR/ mice are more susceptible to chemically induced
skin carcinogenesis compared with wild-type mice (Zinser
et al., 2002), suggesting a genoprotective role for VDR in the
skin. However, the significance of the 1aOHase enzyme, and
thus the 1,25(OH)2D3 ligand, in preventing skin tumor
development is not known. Therefore, we compared
skin tumor development in wild-type, VDRþ /, VDR/,
CYP27B1þ /, and CYP27B1/ mice receiving two oral
doses of the chemical carcinogen DMBA using a dosing
regimen described previously for VDR/ mice (Zinser et al.,
2002). Mice were monitored for skin tumor development on
a weekly basis. All VDR/ mice developed skin tumors
within 10–12 weeks after receiving DMBA (Figure 1a). A
representative VDR/ mouse bearing multiple tumors is
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Figure 1. Protection against chemically induced skin tumorigenesis is
VDR-dependent and 1aOHase-independent in mice. VDRþ /þ (n¼11),
VDRþ / (n¼ 6), and VDR/ mice (n¼10); CYP27B1þ /þ (n¼10),
CYP27B1 þ / (n¼ 11), and CYP27B1/ mice (n¼ 10); and VDR/
CYP27B1/ mice (n¼ 13) were given two doses of DMBA by oral gavage
at 5 and 6 weeks of age. Mice were monitored weekly by palpation and
visual inspection for tumor development. (a) Probability of tumor
development was analyzed according to the method of Kaplan–Meier.
VDRþ /þ and CYP27B1þ /þ mice were grouped for statistical analysis.
Mice were censored if they died or if they required euthanasia due to extreme
sickness before developing a skin tumor. (b) A representative image of a
VDR/ mouse bearing several DMBA-induced skin tumors.
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shown in Figure 1b. Skin tumors were classified as sebaceous
hyperplasias (15%), adenomas (70%), or carcinomas (5%)
depending on the ratio of well-differentiated sebocytes to
epithelial keratinocytes. These tumors, like many of the
tumors previously reported in VDR/ skin (Zinser et al.,
2002), likely originated from the folliculosebaceous unit. In
addition, 10% of tumors were classified as warts due to signs
of viral change, such as koilocytic change, church-spire
parakeratin, and dilated blood vessels in the stroma. In
striking contrast to VDR/ mice, no skin tumors were obser-
ved in wild type or CYP27B1/ mice during the 8 months
of the study. In addition, no tumors were observed in mice
heterozygous for the VDR or CYP27B1 genes. Since
CYP27B1/ mice lack detectable levels of circulating
1,25(OH)2D3 (Dardenne et al., 2001; Panda et al., 2001),
these data indicate that VDR, but not its 1,25(OH)2D3 ligand,
is required for protection from DMBA-induced tumorigenesis.
To test whether loss of 1,25(OH)2D3 can further sensitize
VDR/ mice to tumorigenesis, we generated mice deficient
in both VDR and CYP27B1 (double knockout mice) and
administered DMBA as described above. Average time to
tumor development was virtually identical in VDR/ and
VDR/ CYP27B1/ mice (10.6 (±1.1) and 10.7 (±1.2)
weeks after DMBA exposure, respectively). These data
indicate that loss of 1,25(OH)2D3 through genetic deletion
of the 1aOHase enzyme does not increase susceptibility of
mice to tumorigenesis whether or not they express the VDR.
VDR protects mice from UV-induced skin tumorigenesis
UV light causes the majority of human skin cancers, and as
it both initiates and promotes tumorigenesis, is considered to
be a complete carcinogen. To determine whether VDR
protects the skin against UV-induced skin cancer, VDR/
and wild-type mice were chronically exposed to UVB three
times per week for 33 weeks, and monitored weekly for
tumor development for 45 weeks. CYP27B1/ mice were
not included in this study as they lack an overt skin or hair
phenotype, and as they are completely resistant to the
aggressive, rapid-onset, chemically induced carcinogenesis
paradigm.
VDRþ /þ and VDR/ mice were shaved and depilated
as needed to maintain bare skin during the course of
thrice-weekly UV treatments. VDR/ mice began to develop
tumors after approximately 18 weeks of UV exposure, and
half of the VDR/ mice had developed at least one tumor by
30 weeks into the study (Figure 2a). All of the VDR/ mice
that completed the 45-week study developed at least one
tumor. In contrast, only three wild-type mice developed
tumors by this time, and these tumors appeared much later
than those in the VDR/ mice (36–44 weeks after the start of
UV). All but one of the VDR/ tumors were classified as
squamous in origin (Table 1). Sixty percent of VDR/ tumors
were squamous papillomas, with various degrees of atypia
and dysplasia. Benign papillomas (Figure 2d) typically had a
larger amount of keratinized material than more atypical
papillomas, indicating a greater degree of cellular differentia-
tion. The moderate papillomas contained parakeratin, indi-
cative of a defect in the differentiation process (Figure 2f).
Moderate papillomas also contained more proliferating-cell
nuclear antigen (PCNA)-positive cells than benign papillomas
(Figure 2g and e, respectively), indicating a higher proli-
ferative index. Nearly 20% of VDR/ tumors were malignant
squamous cell carcinomas (SCCs) in situ, showing high
degree of atypia, many mitotic figures, and disordered skin
structure. An additional 20% of VDR/ tumors were invasive
SCCs containing a large percentage of proliferating cells
(Figure 2i), significant atypia and disordered structure, and
invasion of the surrounding tissue (Figure 2h). One invasive
SCC was observed in a wild-type mouse, but the remaining
VDRþ /þ tumors were a dermal hyperproliferation, with
characteristics consistent with atypical fibroxanthoma
(AFX). These tumors had a high proliferative index, as shown
by the large number of PCNA-expressing cells (Figure 2k), a
disordered growth pattern, and in some cases contained
black pigmentation (Figure 2j). One VDR/ mouse deve-
loped this type of tumor, suggesting that AFX is not unique
to the wild-type mice.
UV induces p53 protein levels equally in wild-type and
VDR/ keratinocytes
Tumorigenesis occurs after normal cells have sustained
multiple insults and have been subject to growth promotion
(Matsumura and Ananthaswamy, 2002). Therefore, long-term
susceptibility to tumorigenesis may be determined by the
ability of the skin to deal with acute UV-induced damage.
DNA damage causes stabilization and upregulation of the
p53 tumor-suppressor protein (Maltzman and Czyzyk, 1984).
Phosphorylation increases p53 protein stability and transcrip-
tional activity (Siliciano et al., 1997). Active p53 either halts
the cell cycle so that cellular damage can be repaired, or
initiates apoptosis. To determine whether VDR/ mice have
a defect in the p53 response, primary mouse keratinocytes
were isolated from wild-type and VDR/ mice. Cells were
exposed to UVB and protein was harvested at various time
points. Western blot analysis indicated that p53 was
upregulated as early as 4 hours after UV exposure, protein
levels peaked at 8 hours, and subsequently declined at 24 and
48 hours (Figure 3). Notably, p53 levels were similar in
VDRþ /þ and VDR/ keratinocytes. We also observed
UV-induced increases in the levels of phosphorylated serine
15 p53 that were comparable in wild-type and VDR/
keratinocytes at each time point after UV exposure (Figure 3),
suggesting that this important, early response to UV in
keratinocytes is not dramatically altered in VDR/ keratino-
cytes.
Incomplete repair of thymine dimers in VDR/ epidermis
as compared with wild type
p53 upregulation institutes cell-cycle arrest, which allows
time for DNA repair. If UV-induced thymine dimers are not
repaired before a cell replicates, this damage transforms into
permanent mutations in the genetic code. To address
an in vivo role of VDR in thymine-dimer repair, wild-type
and VDR/ newborn mice were irradiated with UV and skin
was harvested at the indicated time points. Genomic DNA
was isolated from the epidermis and thymine dimers were
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quantified by southwestern slot blotting using an antibody
recognizing this form of DNA damage. As expected,
untreated epidermis lacked detectable thymine dimers
(Figure 4). In wild-type epidermal samples, the levels of
thymine dimer were highest immediately following irradia-
tion, and gradually decreased over time, nearly returning to
baseline levels at 24 hours after irradiation. In contrast, levels
of thymine dimers were higher in VDR/ epidermis as
compared with the wild type at each time point, and the
amount of thymine dimers remained significantly higher in
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Figure 2. VDR protects mice from UV-induced skin tumorigenesis. (a) VDRþ /þ (n¼23) and VDR/ (n¼ 22) mice were shaved and treated with a depilatory
lotion, and then exposed to UV thrice weekly for 33 weeks as described under Materials and Methods. Mice were monitored weekly by palpation and
visual inspection for tumor development. Probability of tumor development was analyzed according to the method of Kaplan–Meier. Mice were censored if they
died or if they required euthanasia due to extreme sickness before developing a skin tumor. (b) Representative image of thickened but non-tumor-bearing
skin from a wild-type mouse after 26 weeks of regular UV exposure. Bar¼ 20 mm. (c) Representative image of thickened but non-tumor-bearing skin from
a VDR/ mouse after 29 weeks of regular UV exposure. Bar¼20 mm. Histological appearance of a representative benign papilloma (d, e), moderate papilloma
(f, g), an invasive SCC (h, i), and an AFX (j, k). Images were taken of hematoxylin and eosin-stained paraffin-embedded sections (d, f, h, j), and of sections
immunohistochemically stained with an antibody against PCNA to indicate proliferation (e, g, i, k). PCNA-positive cells appear brown. Bar (d–k)¼ 20 mm.
Table 1. Histological classification of tumors induced
by UV irradiation in wild-type and VDR/ mice
Papilloma
Benign Mild Moderate Severe SCC in situ Inv SCC AFX Total
WT 0 0 0 0 0 1 3 4
KO 4 5 6 1 5 5 1 27
AFX, atypical fibroxanthoma; KO, knockout; SCC, squamous cell
carcinoma; VDR, vitamin D receptor; WT, wild type.
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VDR/ epidermis than in the wild type at 24 hours after UV
exposure (Figure 4), indicating that keratinocyte DNA-repair
pathways are compromised by VDR ablation.
UVB-induced growth arrest is compromised in
VDR/ keratinocytes in vitro
Growth arrest is a critical, immediate response of keratino-
cytes to UV exposure so that effective repair of the damage
may occur prior to DNA replication (Petrocelli et al., 1996).
Failure to provide this important window for repair leads to
propagation of the damage and cancer. Therefore, we tested
whether VDR/ keratinocytes displayed altered proliferative
responses to UV exposure in vitro. Wild-type and VDR/
keratinocytes were irradiated once with various doses of UVB
and proliferation was monitored for 3 days using the MTT
assay. Confirming previous reports (Sakai and Demay, 2000),
non-irradiated wild-type and VDR/ keratinocytes grew at
similar rates in vitro (Figure 5a and b). Exposure of VDRþ /þ
keratinocytes to a 25-mJ cm2 dose of UVB attenuated their
growth rate at 24 and 48 hours following a single UV
exposure. In contrast, VDR/ keratinocytes were virtually
unaffected by this dose of UVB. A higher level of UVB
exposure (50mJ cm2) effectively blocked the growth of wild-
type keratinocyte at 24 and 48 hours (Figure 5a). The VDR/
keratinocytes continued to grow at this higher UV dose, albeit
more slowly (Figure 5b). These data indicate that VDR/
keratinocytes are defective in UV-induced growth arrest as
compared with their wild-type counterparts.
In vivo apoptotic defects in VDR/ keratinocytes
following a single dose of UV
In addition to growth arrest and repair, keratinocytes undergo
apoptosis if cellular damage is too severe to be repaired.
Figure 6 illustrates proliferative and apoptotic responses of
keratinocytes in vivo following exposure of VDRþ /þ and
VDR/ mice to a single dose of UVB. Shaved and depilated
dorsal skin of wild-type and VDR/ mice were exposed to a
120-mJ cm2 dose of UV and skin was harvested 24 hours
later. Proliferative keratinocytes were visualized by PCNA
staining. Apoptotic cells were fluorescently labeled by the
TUNEL method and nuclei were counterstained with 4,
6-diamino-2-phenylindole. Differences in proliferation
were not apparent in vivo, perhaps due to the nature of
this single, high dose of UVB (Figure 6a). However, VDR/
skin contained less than half the number of apoptotic
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Figure 3. UV induces p53 protein levels and p53 phosphorylation equally
in wild-type and VDR/ keratinocytes. Keratinocytes were isolated from
newborn wild-type and VDR/ mice, allowed to grow for 24 hours, and
irradiated with 50mJ cm2 of UVB through a thin film of PBS. Media were
replaced and protein was harvested at the indicated time points. Protein
expression was analyzed by western blotting.
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Figure 4. Incomplete repair of thymine dimers in VDR/ epidermis
compared with wild type. Newborn mice were exposed to 120mJ cm2 of
UV and skin was collected at the indicated time points. Epidermal genomic
DNA was isolated and thymine dimers were measured by southwestern slot
blot. Thymine dimers were normalized to total genomic DNA with a
radiolabeled mouse genomic DNA probe. Thymine dimers were measured in
the epidermis of 2–3 individual mice for each time point, except for the
unirradiated control. The data shown represent the mean from three
independent measurements of thymine dimers relative to total genomic DNA
from the epidermal samples. Error bars represent SEM; *Po0.04.
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Figure 5. UVB-induced growth arrest is compromised in VDR/
keratinocytes in vitro. Primary keratinocytes were isolated from newborn
wild-type and VDR/ mice, allowed to grow for 24 hours, and irradiated
with the indicated amount of UVB through a thin film of PBS. Media were
replaced and cell proliferation was measured at the indicated time points
using the MTT assay as described under Materials and Methods. Cell growth
of (a) wild-type and (b) VDR/ keratinocytes is plotted over time. Error bars
represent SD.
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keratinocytes as compared with wild-type skin (Figure 6b).
This finding suggests that tumor susceptibility in VDR/
mice may also derive from a decreased ability to eliminate
damaged cells from the skin due to defective keratinocyte
apoptosis.
Defective epidermal thickening of VDR/ skin in response
to chronic UV exposure
Following UV-induced cell-cycle arrest and repair, keratino-
cytes enter a hyperproliferative stage in order to replace cell
loss due to apoptosis (that is, sunburn cells) and to increase
the number of epidermal cell layers to protect basal cells
against additional UV exposure (de Winter et al., 2001).
Differences in the ability to adapt to chronic UVB exposure
may explain the variation in long-term susceptibility to
UV-induced tumorigenesis. Wild-type and VDR/ mice
(5–7 weeks old) were exposed to UVB six times over a period
of 2 weeks. Skin samples were obtained 24 hours after the
final dose, stained for PCNA expression to indicate proli-
ferating cells, and epidermal thickness was measured.
Representative sections of VDRþ /þ and VDR/ skin after
the final dose of UV are shown in Figure 7b. Virtually all
keratinocytes in the basal layer were proliferating in both the
VDRþ /þ and VDR/ skin, but the wild-type epidermis
contained an abundance of keratinocytes proliferating above
the basal layer. This effect required repeated doses, since,
as previously shown, PCNA-positive keratinocytes in the
epidermal layers were similar in wild-type and VDR/
epidermis following a single, acute, exposure to UVB
(Figure 6a). Following more chronic exposure to six doses
of UV, the PCNA-positive VDRþ /þ keratinocytes were at a
level of 72%, whereas PCNA-positive VDR/ keratino-
cytes were at a significantly lower level of 56% (Po 0.025;
Figure 7a). These differences in the proliferative index
correlated to differences in epidermal thickness between
wild-type and VDR/ skin. Average epidermal thickness was
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Figure 6. In vivo apoptotic defects in VDR/ keratinocytes following a
single dose of UV. Wild-type (WT, n¼4) and VDR/ (KO, n¼ 4) mice were
exposed to 120mJ cm2 of UV and a biopsy was collected 24 hours later.
(a) Skin samples were stained for PCNA expression and counterstained with
hematoxylin (positive cells are brown). PCNA-positive keratinocytes in WT
and KO skin were counted as a percentage of total number of keratinocytes.
Error bars represent SEM. Representative sections are shown on the right.
Bar¼20 mm. (b) Apoptotic cells were labeled by the TUNEL method and
nuclei were counterstained with 4,6-diamino-2-phenylindole. Apoptosis rates
were calculated as the number of TUNEL-positive cells as a percentage of
total epidermal keratinocytes from multiple fields of TUNEL-labeled, paraffin-
embedded skin sections, viewed at an original magnification of  100. Error
bars represent SD. Differences were analyzed by the two-tailed Student’s
t-test; *P¼ 0.005. Representative fields of TUNEL-labeled sections are on the
right, showing TUNEL-positive cells in green and nuclei in blue. Bar¼ 20 mm.
Dotted lines indicate the epidermal–dermal junction.
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Figure 7. Defective epidermal thickening of VDR/ skin in response to
chronic UV exposure. Wild-type (WT, n¼ 4) and VDR/ (KO, n¼ 4) mice
were exposed to six doses of UV (120mJ cm2) during a 2-week period. Skin
samples were collected and fixed 24 hours after the final dose. (a) Skin
samples were stained for PCNA expression and counterstained with
hematoxylin. PCNA-positive keratinocytes in WT and KO skin were counted
as a percentage of total number of keratinocytes. Wild-type epidermis was
significantly more proliferative than VDR/ epidermis following six
exposures of UV; *Po0.025. Error bars represent SEM. Differences were
analyzed by two-tailed Student’s t-test. (b) Representative sections of
wild-type and VDR/ skin, stained for PCNA expression. Brackets indicate
epidermal thickness. Bar¼40 mm. (c) Epidermal thickness was calculated
from 20–25 measurements from multiple fields of paraffin-embedded skin
sections, viewed at an original magnification of  100. Error bars represent
SD. Differences in thickness were analyzed by two-tailed Student’s t-test.
Wild-type epidermis was significantly thicker than VDR/ epidermis
following six exposures of UV, *Po0.015.
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similar in wild-type and VDR/ mice that were not
exposed to UV (14.7±3.6 and 17.4±5.4 mm, respectively)
(Figure 7c). Differences in epidermal thickness of 24-hour
VDRþ /þ and VDR/ skin were not apparent following a
single, acute, exposure 24 hours post UV treatment. How-
ever, following six doses of UV the average epidermal
thickness of wild-type mice increased eightfold compared
with that in unexposed mice, whereas average thickness in
VDR/ mice increased less than threefold. This indicates a
significant difference in UV-induced epidermal thickening in
wild-type mice as compared with VDR/ mice. The reduced
levels of keratinocyte proliferation and apoptosis in VDR/
skin in response to UV exposure suggest that these mice do
not mount a sufficient defense against the damage caused by
UV radiation, which compounded over a chronic series of
UV exposures leaves them more susceptible to UV-induced
skin tumorigenesis.
DISCUSSION
Arguably, one of the most remarkable observations derived
from the vitamin D endocrine system-knockout mouse
models centers on the lack of a profound skin and hair
phenotype in the CYP27B1/ mice as compared with the
defects observed in VDR/ skin. These mouse models are
consistent with rare genetic diseases resulting from inactiva-
tion of VDR and CYP27B1 in humans. That is, many patients
with hereditary vitamin D-resistant rickets (resulting from
inactivating mutations of VDR) present with alopecia,
whereas those with pseudo-vitamin D deficiency rickets
(resulting from inactivation of the 1aOHase enzyme) do not
(Hughes et al., 1988; St-Arnaud et al., 1997). Indeed, classic
dietary deficiency studies over the past century support
these more modern genetic approaches, in that vitamin D
deficiency does not significantly impact skin or hair. These
and other observations led to the hypothesis that VDR may
act independently of 1,25(OH)2D3 in keratinocytes. One of
the most significant aspects of this study is that the ligand-
independent nature of VDR function in the skin can now be
extended to a second global process, namely, protection
against chemically induced skin tumorigenesis. The
CYP27B1/ mice are remarkably resistant to chemically
induced skin tumor development using a paradigm in which
all of the VDR/ mice developed multiple tumors per
animal. Clearly, lack of systemic 1,25(OH)2D3 has no impact
on the sensitivity of mouse skin to chemically induced
tumorigenesis, whereas lack of VDR does. Mechanisms
involved in this difference in cancer susceptibility remain to
be defined.
Several possibilities exist that explain the apparent
uncoupling of VDR and 1,25(OH)2D3 in both hair follicle
cycling and in protection against DMBA-induced skin
tumorigenesis. Whereas systemic 1,25(OH)2D3 is undetect-
able in CYP27B1/ mice (Dardenne et al., 2001; Panda
et al., 2001), it is possible that local production of
1,25(OH)2D3 occurs in the CYP27B1
/ keratinocytes.
Keratinocytes synthesize 1,25(OH)2D3 (Bikle et al., 1986)
where it may act in an autocrine/paracrine manner to control
keratinocyte differentiation and function. However, keratino-
cyte production of 1,25(OH)2D3 is thought to be mediated
through the CYP27B1 gene product (Fu et al., 1997).
Alternatively, a CYP27B1-independent pathway may cata-
lyze local production of 1,25(OH)2D3. However, in vivo and
in vitro experiments argue against CYP27B1-independent
synthesis of 1,25(OH)2D3 in the skin. For example, VDR
(L233S), a mutated form of VDR, which is incapable of
binding 1,25(OH)2D3, rescues the VDR
/ defect in hair-
follicle cycling when expressed in basal keratinocytes of the
VDR/ mouse (Skorija et al., 2005). The activity of VDR
L233S supports the possibility that VDR activity in the skin is
regulated by a previously unreported skin-selective ligand, or
potentially no ligand at all. We recently showed in vitro
evidence for a keratinocyte-selective, 1,25(OH)2D3-indepen-
dent transactivation by VDR that supports this idea (Ellison
et al., 2007). VDR activity is regulated by post-translational
modifications such as phosphorylation. For example, okadaic
acid, a protein phosphatase inhibitor, increases both
1,25(OH)2D3-dependent and 1,25(OH)2D3-independent acti-
vation of VDR by promoting interaction between VDR and
the VDR-interacting protein 205 coactivators (Barletta et al.,
2002). Thus, it is possible that keratinocyte growth factor
pathways may impinge on VDR to activate this nuclear
receptor in keratinocytes through a 1,25(OH)2D3-indepen-
dent mechanism. Additional studies in this vein may produce
novel strategies of targeting VDR pharmacologically in the
skin.
Another key finding of these studies is that VDR protects
against skin tumorigenesis induced by UV irradiation, the
cause of skin cancer most relevant to human disease. VDR/
mice exposed chronically to UV light developed tumors with
a mean latency much shorter than that in wild-type controls
(Figure 2a). The requirement for the 1,25(OH)2D3 ligand in
protecting against UV-induced tumorigenesis remains an
open question. Since DMBA and UV radiation induce
tumorigenesis by different mechanisms, it is possible that
1,25(OH)2D3 may play a protective role here. Indeed, recent
studies suggest that pharmacological application of vitamin D
compounds may reduce cell death and enhance DNA repair
in mouse skin following UV exposure (Dixon et al., 2007).
In that study, analogs selective for a non-genomic, VDR-
independent signaling pathway were effective and this raised
the intriguing possibility that the 1,25(OH)2D3 ligand could
protect against UV-induced skin tumorigenesis in a receptor-
independent manner. This putative non-genomic pathway
represents another paradigm in which actions of VDR and its
1,25(OH)2D3 ligand may be uncoupled in skin physiology.
Early responses of keratinocytes to UV exposure and
damage occur through p53-dependent and p53-independent
pathways (Maltzman and Czyzyk, 1984; Lee et al., 1997;
Melino et al., 2002). Data presented here indicate that VDR
expression is not critical for UV-induced upregulation of
p53 protein levels and activity in keratinocytes. Both total
and phosphorylated p53 were upregulated to the same extent
in VDR/ and wild-type keratinocyte cultures (Figure 3).
The intact p53-response pathway in VDR/ keratinocytes
predicts that DNA repair would be equal in wild-type and
VDR/ epidermis. However, thymine-dimer repair was
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markedly attenuated in newborn VDR/ epidermis as
evidenced by the significantly higher levels of thymine
dimers that remained in VDR/ epidermis as compared
with wild-type controls 24 hours following a single UV dose.
Although it will be important to extend these studies to older
animals, these studies clearly indicate that the VDR/mouse
has defective DNA-repair pathways. Cumulatively, these data
support a role for VDR in regulating one or more p53-
independent mechanisms involved in UV-induced DNA
damage repair.
UV causes a multi-step cascade of events in exposed cells
(Matsumura and Ananthaswamy, 2002). Initially, cell growth
is arrested so that DNA damage may be repaired. Those
keratinocytes that harbor extensive cellular damage, which is
beyond repair, undergo apoptosis. After an initial period of
cell-cycle arrest, proliferation ensues in order to replace cells
lost to apoptosis. As a result of hyperproliferation, the
epidermis becomes thickened so that upper layers of the
epidermis protect the basal layer of keratinocytes from future
exposure to UV. Our data indicate that VDR may play
important roles in each of these cellular responses to UV. For
example, acute UV exposure reduced growth of wild-type
keratinocytes, whereas VDR/ keratinocytes remained more
proliferative (Figure 5a and b). These data indicate that
VDR is important for growth arrest immediately following
UV exposure. Fewer apoptotic cells were detected in vivo
in VDR/ skin as compared with in VDRþ /þ skin following
a single dose of UVB. This suggests that VDR also plays a role
in detecting the need for apoptosis or is involved in executing
the cell death process itself (Figure 6b). In either case, it is
likely that damaged keratinocytes remain in VDR/ skin
following UV exposure. Following repeated UV exposures
over a 2-week period, wild-type keratinocytes in the
epidermis became more proliferative and epidermal thick-
ness increased to a greater extent in wild-type skin as
compared with in VDR/ skin (Figure 7). These data suggest
that VDR/ mice are more sensitive to skin tumorigenesis
induced by chronic UV treatment because they are unable to
mount an effective thickening of their epidermal layer as
compared with wild-type mice. Indeed, previous studies have
illustrated an important role for epidermal thickening in
protecting basal keratinocytes from subsequent DNA damage
caused by UV (de Winter et al., 2001). Finally, the enhanced
basal proliferation of VDR/ keratinocytes previously
observed in vivo (Zinser et al., 2002), and the reduced
proliferation and epidermal thickening of VDR/ keratino-
cytes in response to chronic UV, observed in these studies,
indicate that VDR exerts opposing actions on these two
distinct proliferative pathways. The identification of VDR-
regulated genes involved in these pathways will be the next
important goal. To this end, the VDR/ keratinocyte cell
system will prove extremely valuable.
MATERIALS AND METHODS
Animal maintenance
All studies were approved by the Institutional Animal Care and Use
Committee at Case Western Reserve University. Mice lacking the
CYP27B1 gene (CYP27B1/) (Dardenne et al., 2001) and VDR gene
(VDR/) (Li et al., 1997) were generously provided by R St-Arnaud
(Shriners Hospital for Children, Montreal, Quebec) and M Demay
(Massachusetts General Hospital and Harvard Medical School,
Boston, MA), respectively. Both lines of mice are on a homogeneous
C57BL/6 genetic background having been back-crossed greater than
10 times into this strain. VDR/ CYP27B1/ double knockout mice
were generated by mating mice heterozygous for both the genes.
Mouse genotyping was performed with tail DNA as previously
described (Ellison et al., 2007). Mice were fed a diet containing 2%
calcium, 1.25% phosphorus, and 20% lactose supplemented with
2.2 IU of vitamin D3 per gram (TD96348; Teklad, Madison, WI),
which has been shown to normalize serum mineral homeostasis,
skeletal growth, bone density, and body weight in CYP27B1/
(Dardenne et al., 2003) and VDR/ mice (Li et al., 1998).
Chemical carcinogen treatment and tumor monitoring
VDRþ /þ , VDRþ /, and VDR/ mice (n¼ 7 of each); CYP27B1þ /þ ,
CYP27B1þ /, and CYP27B1/ mice (n¼ 11 of each); and VDR/
CYP27B1/ double knockout mice (n¼ 12) were treated with
DMBA (100mg kg1 body weight) in corn oil by oral gavage at 5 and
6 weeks of age as described previously (Zinser et al., 2002). Mice
were examined weekly for tumor development by visual inspection
and palpation. Mice bearing a skin growth 1mm or larger, persisting
for more than 7 days, were scored positive.
UVB irradiation and tumor monitoring
Dorsal skin was shaved with electric clippers and depilated with
Nair lotion 24 hours before UVB exposure. Mice (5–7 weeks old at
the onset of the study) were irradiated three times per week, with 2–3
days between treatments, and re-depilated as needed. The dorsal
skin was exposed to UV irradiation from a band of six FS-40
fluorescent lamps; UVB and UVC wavelengths not normally present
in natural solar radiation were filtered out from this UV light using
Kodacel cellulose film. After filtration with a Kodacel film, the UVB
wavelengths ranged from approximately 290 to 320 nm. UVB
emission was monitored with an IL-443 phototherapy radiometer
(International Light, Newburyport, MA) equipped with an IL SED 240
detector fitted with a W side angle quartz diffuser and a SC5 280
filter. The dose of UVB varied to maximize UV exposure with
minimal ulceration of the skin. Mice received 120mJ cm2 for
2 weeks. The dose was then increased 25% per week for 5 weeks,
reaching the maximal dose of 400mJ cm2. This dose was
administered for 9 weeks. With advancing age, the skin of
several mice became increasingly ulcerated so the dose was reduced
to 200mJ cm2 for the rest of the study. Mice received UVB
treatments for 33 weeks, and were examined weekly for tumor
development by visual inspection and palpation. Mice bearing a skin
growth 1mm or larger, persisting for more than 7 days, were scored
positive.
Another cohort of mice (5–7 weeks old) were depilated as
described above and exposed to 120mJ cm2. Twenty-four hours
later, mice were anesthetized with Avertin, and a biopsy was taken
from the dorsal skin and fixed in neutral buffered formalin. Mice
were exposed to five additional doses of UV and another sample of
skin was collected. TUNEL staining was performed on the skin
samples following the first dose of UV, and PCNA staining and
epidermal thickness measurement was performed on all skin
samples, as described below.
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Tumor classification
Tumors were collected at death or by excision biopsy, fixed in
neutral buffered formalin, and embedded in paraffin. Sections
measuring 5 mm were stained with hematoxylin and eosin, and
evaluated in a blinded manner. DMBA tumors were classified as a
sebaceous hyperplasia if more than 90% of the cells were well-
differentiated mature sebocytes, or sebaceous adenoma if approxi-
mately 50% of the cells were well-differentiated mature sebocytes.
UV-induced tumors were classified as a papilloma, either benign or
with mild, moderate, or severe dysplasia, as a SCC, either in situ or
invasive, or as an AFX. Benign papillomas had few to no mitotic
structures above the basal epidermal layer and no cytological atypia.
Mild, moderate, and severe atypia papillomas had parakeratin,
increasing numbers of mitotic figures above the basal layer, and
increasing likelihood of cytological atypia. SCC in situ was
characterized by parakeratosis, and high likelihood of hyperkeratosis,
dyskeratosis, and acanthosis. There were many atypical keratinocytes
with hyperchromatism, pleomorphism, atypical mitoses, and loss of
orderly maturation (sometimes creating a ‘‘windblown’’ appearance).
In some cases, the epidermis showed evidence of a loss of polarity.
Invasive SCC was characterized by the descriptors mentioned above
for SCC in situ, with the addition of invasion of the dermis by atypical
keratinocytes and the lack of a defined basal layer. Some mice
developed rapidly growing tumors consisting of dermal proliferation
of atypical spindle cells, epithelioid cells, or multinucleated giant
cells, and, sometimes, foamy cells often extending up against the
epidermis. Tumors contained severe pleomorphism, hyperchroma-
tism, and many very atypical mitoses, consistent with AFX.
Immunoblotting
Primary mouse keratinocytes were isolated as previously described
(Ellison et al., 2007) and cultured in keratinocyte-serum-free medium
(Invitrogen, Carlsbad, CA) on collagen-I plates (Corning, Lowell, MA).
Cells were exposed to UVB through a thin film of phosphate-buffered
saline (PBS) and media were replaced. Protein was harvested in sample
buffer (62.5mM Tris (pH 6.8), 10% glycerol, 2% sodium dodecyl
sulfate) and protein concentration was determined by BCA assay
(Pierce, Rockford, IL). b-Mercaptoethanol (1%) and bromphenol blue
(0.01%) were added and equal amounts of protein were separated on
polyacrylamide gels. Protein was transferred to polyvinylidene
difluoride membrane (Immobilon-P; Millipore, Billerica, MA) and
probed for p53 (sc-6243, 1:400; Santa Cruz Biotechnology, Santa
Cruz, CA), phospho-serine15 p53 (1:1,000; Cell Signaling Technology,
Danvers, MA), or actin (1:20,000; Sigma-Aldrich, St Louis, MO).
Membranes were washed and probed with the species appropriate
secondary antibody at a 1:10,000 dilution, and then the signal was
visualized by chemiluminescence.
Slot-blot analysis of thymine dimers
Newborn VDRþ /þ and VDR/ mice were treated with
120mJ cm2 of UV and skin was harvested at the indicated time
points. Unirradiated skin was also collected as a control. Skin was
floated in dispase (BD Biosciences, Bedford, MA) for 20minutes at
37C, and then the epidermis was removed with forceps. Epidermis
was digested overnight in lysis solution with proteinase K (supplied
with the kit) and genomic DNA was purified using DNeasy columns
(Qiagen Inc., Valencia, CA). Prior to DNA purification, the solution
was treated for 2minutes at room temperature with RNaseA
(2mgml1; Sigma-Aldrich). After elution, DNA was further purified
by standard phenol/chloroform extraction and ethanol precipitation.
DNA concentration was determined using a spectrophotometer.
DNA was denatured by boiling in 0.4M NaOH/10mM EDTA for
10minutes. Ice-cold ammonium acetate (2 M) was added to a final
concentration of 1 M. A 50 ng weight per well of DNA was spotted
onto a wet nitrocellulose membrane (Biotrace NT; VWR Interna-
tional, West Chester, PA) using a Bio-Dot SF apparatus (Bio-Rad
Laboratories, Hercules, CA). The membrane was washed with 0.4 M
NaOH/10mM EDTA, removed from the apparatus, and baked under
vacuum for 30minutes at 80 1C. The membrane was incubated with
a primary antibody recognizing thymine dimers (1:2500, clone
KTM53; Kamiya Biomedical Company, Seattle, WA), followed by
washing and incubation with a goat anti-mouse secondary antibody
(1:10,000; KPL, Gaitherburg, MD). Signal was visualized by
chemiluminescence. Thymine-dimer signal was normalized to total
genomic DNA by probing with radiolabeled mouse genomic DNA.
Genomic DNA was 32P labeled using the Prime-a-Gene kit (Promega,
Madison, WI) according to the manufacturer’s instructions.
MTT assay
Primary mouse keratinocytes were isolated and cultured as
described above. Twenty-four hours after plating, cells were exposed
to UV through a thin film of PBS and media were replaced.
Proliferation rate was measured at the indicated time periods by
incubating cells with MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide, 0.5mgml1 final concentration) for 1 hour.
Cells were washed twice with PBS and cells were lysed with
isopropanol with 0.04 N HCl. Absorbance at 560 nm was measured
using a plate spectrophotometer.
Histological analysis of skin
Epidermal thickness was calculated from 20–25 measurements from
multiple fields of paraffin-embedded skin sections immunohisto-
chemically stained for PCNA expression, and viewed at an original
magnification of  100. Measurements were made using Axiovision
software (Carl Zeiss, Thornwood, NY). Differences in thickness were
analyzed by the two-tailed Student’s t-test in Microsoft Excel.
Immunohistochemistry was performed with paraffin-embedded
sections using Vectastain avidin–biotin peroxidase and peroxidase
DAB kits (Vector Laboratories, Burlingame, CA). Briefly, skin
sections were deparaffinized with xylene and rehydrated in ethanol
at decreasing concentrations. Sections were boiled for 20minutes in
10mM citrate buffer, pH 6, for antigen retrieval, and endogenous
peroxidase was blocked using 3% H2O2. For PCNA staining,
sections were blocked in PBS with 1.5% horse serum, followed by
overnight incubation with the primary antibody (PCNA sc-56; Santa
Cruz Biotechnology), followed by a biotinylated horse anti-mouse
secondary antibody (1:200; Vector Laboratories) and conjugation
with the avidin–biotin peroxidase complex. Sections were counter-
stained with Gill’s hematoxylin #2 (Fisher Scientific, Pittsburgh, PA),
dehydrated, cleared, and mounted in Permount. A control (buffer
without primary antibody) was performed for each tissue stained.
Apoptotic cells were detected in paraffin-embedded skin sections
using the DeadEnd Fluorometric TUNEL system (Promega) according
to the manufacturer’s instructions, with the following exceptions:
tissue sections were not fixed again following rehydration and tissue
was not treated with proteinase K. Instead, tissue was microwaved
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for 1minute at high power in 100mM citrate buffer, pH 6, and then
incubated for 30minutes in Tris-HCl, pH 7.5, containing 3% BSA
and 20% normal bovine serum. Slides were washed twice in PBS
before continuing with the manufacturer’s labeling protocol. Cover-
slips were mounted on slides with Vectashield mounting medium
containing 4,6-diamino-2-phenylindole (Vector Laboratories).
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